0000899866-20-000046.txt : 20200518 0000899866-20-000046.hdr.sgml : 20200518 20200518171543 ACCESSION NUMBER: 0000899866-20-000046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200514 FILED AS OF DATE: 20200518 DATE AS OF CHANGE: 20200518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COUGHLIN CHRISTOPHER J CENTRAL INDEX KEY: 0001110750 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 20890645 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 4752302596 MAIL ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960111 4 1 wf-form4_158983652588830.xml FORM 4 X0306 4 2020-05-14 0 0000899866 ALEXION PHARMACEUTICALS, INC. ALXN 0001110750 COUGHLIN CHRISTOPHER J C/O ALEXION PHARMACEUTICALS, INC 121 SEAPORT BOULEVARD BOSTON MA 02210 1 0 0 0 Common Stock, par value $.0001 per share 2020-05-14 4 A 0 3468 0 A 36882 D Common Stock, par value $.0001 per share 2020-05-14 4 A 0 2774 0 A 39656 D Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest in their entirety on the earlier of (i) the first anniversary of the grant date and (ii) the date of the 2021 Annual Shareholder Meeting. Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest as to 25% on a quarterly basis. These Restricted Stock Units were issued in lieu of the annual cash retainer that the director was entitled to receive for service as a director. /s/ Douglas Barry, Attorney-in-Fact for Christopher J. Coughlin 2020-05-18